IL124415A - N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them - Google Patents

N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL124415A
IL124415A IL12441596A IL12441596A IL124415A IL 124415 A IL124415 A IL 124415A IL 12441596 A IL12441596 A IL 12441596A IL 12441596 A IL12441596 A IL 12441596A IL 124415 A IL124415 A IL 124415A
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
bridged bisindolylmaleimides
bisindolylmaleimides
Prior art date
Application number
IL12441596A
Other languages
English (en)
Other versions
IL124415A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21725638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL124415(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL124415A0 publication Critical patent/IL124415A0/xx
Publication of IL124415A publication Critical patent/IL124415A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
IL12441596A 1995-11-20 1996-11-18 N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them IL124415A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US734595P 1995-11-20 1995-11-20
PCT/US1996/018518 WO1997019080A1 (en) 1995-11-20 1996-11-18 Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides

Publications (2)

Publication Number Publication Date
IL124415A0 IL124415A0 (en) 1998-12-06
IL124415A true IL124415A (en) 2003-11-23

Family

ID=21725638

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12441596A IL124415A (en) 1995-11-20 1996-11-18 N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them

Country Status (31)

Country Link
EP (1) EP0776899B1 (xx)
JP (2) JP4100708B2 (xx)
KR (1) KR100342142B1 (xx)
CN (1) CN1066734C (xx)
AR (2) AR004718A1 (xx)
AT (1) ATE191219T1 (xx)
AU (1) AU701659B2 (xx)
BR (1) BR9611709A (xx)
CA (1) CA2237401C (xx)
CO (1) CO4750824A1 (xx)
CZ (1) CZ150398A3 (xx)
DE (1) DE69607443T2 (xx)
DK (1) DK0776899T3 (xx)
EA (1) EA000639B1 (xx)
ES (1) ES2145978T3 (xx)
GR (1) GR3033729T3 (xx)
HU (1) HU225716B1 (xx)
IL (1) IL124415A (xx)
MX (1) MX9803791A (xx)
MY (1) MY118946A (xx)
NO (1) NO310195B1 (xx)
NZ (1) NZ323282A (xx)
PE (1) PE17998A1 (xx)
PL (1) PL184728B1 (xx)
PT (1) PT776899E (xx)
TR (1) TR199800876T2 (xx)
TW (1) TW371661B (xx)
UA (1) UA56145C2 (xx)
WO (1) WO1997019080A1 (xx)
YU (1) YU49316B (xx)
ZA (1) ZA969645B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2245029A1 (en) 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
EP1070068B2 (en) * 1998-03-13 2007-01-17 The University Of British Columbia Granulatimide derivatives for use in cancer treatment
US6127401A (en) 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
US6300106B1 (en) 2000-11-22 2001-10-09 Ppg Industries Ohio, Inc. Method of preparing 3-[2-{(Methylsulfonyl)oxy}-ethoxy ]-4-(triphenylmethoxy)-1-butanol, methane sulfonate
EP2181999A1 (en) 2008-11-03 2010-05-05 Zentiva, A.S. Method of manufacturing ruboxistarin
WO2023192984A1 (en) * 2022-03-31 2023-10-05 4M Therapeutics Inc. N-desmethyl ruboxistaurin as kinase inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
HU219709B (hu) * 1993-12-07 2001-06-28 Eli Lilly And Co. Proteinkináz C gátló hatású kondenzált indolszármazékok, eljárás előállításukra, és az ezeket tartalmazó gyógyászati készítmények
US5559228A (en) * 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides

Also Published As

Publication number Publication date
JP2008138006A (ja) 2008-06-19
PT776899E (pt) 2000-08-31
TW371661B (en) 1999-10-11
KR19990067600A (ko) 1999-08-25
EA000639B1 (ru) 1999-12-29
AU701659B2 (en) 1999-02-04
DE69607443T2 (de) 2000-08-10
NZ323282A (en) 1999-01-28
JP2000500496A (ja) 2000-01-18
JP4100708B2 (ja) 2008-06-11
CA2237401C (en) 2003-10-21
DE69607443D1 (de) 2000-05-04
CN1066734C (zh) 2001-06-06
ZA969645B (en) 1998-05-18
GR3033729T3 (en) 2000-10-31
YU61096A (sh) 1999-03-04
EP0776899B1 (en) 2000-03-29
AR004718A1 (es) 1999-03-10
CN1207740A (zh) 1999-02-10
CZ150398A3 (cs) 1998-12-16
DK0776899T3 (da) 2000-07-10
BR9611709A (pt) 1999-02-23
AR004719A1 (es) 1999-03-10
PL184728B1 (pl) 2002-12-31
UA56145C2 (uk) 2003-05-15
KR100342142B1 (ko) 2002-08-22
HUP9901975A3 (en) 2000-01-28
ES2145978T3 (es) 2000-07-16
EP0776899A1 (en) 1997-06-04
WO1997019080A1 (en) 1997-05-29
ATE191219T1 (de) 2000-04-15
CA2237401A1 (en) 1997-05-29
MY118946A (en) 2005-02-28
MX9803791A (es) 1998-09-30
HU225716B1 (en) 2007-07-30
PE17998A1 (es) 1998-04-20
TR199800876T2 (xx) 1998-08-21
YU49316B (sh) 2005-06-10
PL326753A1 (en) 1998-10-26
NO982105D0 (no) 1998-05-08
IL124415A0 (en) 1998-12-06
NO982105L (no) 1998-05-08
HUP9901975A2 (hu) 1999-11-29
EA199800368A1 (ru) 1998-12-24
AU7738896A (en) 1997-06-11
NO310195B1 (no) 2001-06-05
CO4750824A1 (es) 1999-03-31

Similar Documents

Publication Publication Date Title
IL116770A (en) 2,8-disubstituted quinazolinones their preparation and pharmaceutical compositions containing them
GR3031526T3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL109315A0 (en) 1, 5-benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
HK1017895A1 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
GR3035410T3 (en) Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions
IL113389A0 (en) 1,4-Benzodiazepine compounds, pharmaceutical compositions containing them, their preparation and use
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL100364A0 (en) Benzodiazepinones,their preparation and pharmaceutical compositions containing them
IL117878A0 (en) Taxoids, their preparation and pharmaceutical compositions containing them
IL117815A0 (en) Ascomycins their preparation and pharmaceutical compositions containing them
HUP9801386A3 (en) Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them
IL110366A0 (en) 1,5-Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
IL113366A0 (en) 1,5-benzodiazepine compounds, their preparation and use, and pharmaceutical compositions containing them
IL117808A (en) 1, 3-dihydro-1-(phenylalkenyl)- 2h-imidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
IL117760A0 (en) Taxoids, their preparation and pharmaceutical compositions containing them
IL118672A (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL114623A0 (en) Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
IL117806A (en) 1,3-dihydro-2H-imidazol-2-one derivatives their preparation and pharmaceutical compositions containing them
IL124415A (en) N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them
IL113415A (en) Dihydrodibenziso-quinolinediones their preparation and pharmaceutical compositions containing them
IL111216A0 (en) Heteroarylpiperidines, their preparation and pharmaceutical compositions containing them
GR3036411T3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees